M. Maemondo, A. Inoue, K. Kobayashi, S. Sugawara, S. Oizumi et al., Gefitinib or Chemotherapy for Non???Small-Cell Lung Cancer with Mutated EGFR, New England Journal of Medicine, vol.362, issue.25, pp.2380-2388, 2010.
DOI : 10.1056/NEJMoa0909530

A. Shaw, D. Kim, K. Nakagawa, T. Seto, L. Crinó et al., -Positive Lung Cancer, New England Journal of Medicine, vol.368, issue.25, pp.2385-94, 2013.
DOI : 10.1056/NEJMoa1214886

URL : https://hal.archives-ouvertes.fr/in2p3-00459276

E. Azoulay, G. Thiéry, S. Chevret, D. Moreau, M. Darmon et al., The Prognosis of Acute Respiratory Failure in Critically Ill Cancer Patients, Medicine, vol.83, issue.6, pp.360-70, 2004.
DOI : 10.1097/01.md.0000145370.63676.fb

M. Soares, M. Darmon, J. Salluh, C. Ferreira, G. Thiéry et al., Prognosis of Lung Cancer Patients With Life-Threatening Complications, Chest, vol.131, issue.3, pp.840-846, 2007.
DOI : 10.1378/chest.06-2244

URL : https://hal.archives-ouvertes.fr/inserm-00349094

A. Adam and A. Soubani, Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit, European Respiratory Journal, vol.31, issue.1, pp.47-53, 2008.
DOI : 10.1183/09031936.00031607

F. Pène, S. Percheron, V. Lemiale, V. Viallon, Y. Claessens et al., Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit*, Critical Care Medicine, vol.36, issue.3, pp.690-696, 2008.
DOI : 10.1097/CCM.0B013E318165314B

S. Roques, A. Parrot, A. Lavole, P. Ancel, V. Gounant et al., Six-month prognosis of patients with lung cancer admitted to the intensive care unit, Intensive Care Medicine, vol.34, issue.12, pp.2044-50, 2009.
DOI : 10.1007/s00134-009-1625-y

M. Soares, P. Caruso, E. Silva, J. Teles, S. Lobo et al., Characteristics and outcomes of patients with cancer requiring admission to intensive care units: A prospective multicenter study*, Critical Care Medicine, vol.38, issue.1, pp.9-15, 2010.
DOI : 10.1097/CCM.0b013e3181c0349e

A. Soubani and J. Ruckdeschel, The Outcome of Medical Intensive Care for Lung Cancer Patients, J Thorac Oncol, vol.20, pp.0-000, 2010.

F. Taccone, A. Artigas, C. Sprung, R. Moreno, Y. Sakr et al., Characteristics and outcomes of cancer patients in European ICUs, Critical Care, vol.13, issue.1, p.15, 2009.
DOI : 10.1186/cc7713

C. Andréjak, N. Terzi, S. Thielen, E. Bergot, G. Zalcman et al., Admission of advanced lung cancer patients to intensive care unit: A retrospective study of 76 patients, BMC Cancer, vol.27, issue.6, p.1, 2011.
DOI : 10.3109/07357900903124464

M. Soares, A. Toffart, J. Timsit, G. Burghi, C. Irrazabal et al., Intensive care in patients with lung cancer: a multinational study, Annals of Oncology, vol.25, issue.9, pp.1829-1864, 2014.
DOI : 10.1093/annonc/mdu234

G. Aygencel, M. Turkoglu, T. Sucak, G. Benekli, and M. , Prognostic factors in critically ill cancer patients admitted to the intensive care unit, Journal of Critical Care, vol.29, issue.4, pp.618-644, 2014.
DOI : 10.1016/j.jcrc.2014.01.014

C. Slatore, L. Cecere, J. Letourneau, O. Neil, M. Duckart et al., Intensive Care Unit Outcomes Among Patients With Lung Cancer in the Surveillance, Epidemiology, and End Results???Medicare Registry, Journal of Clinical Oncology, vol.30, issue.14, pp.1686-91, 2012.
DOI : 10.1200/JCO.2011.40.0846

S. Oeyen, D. Benoit, L. Annemans, P. Depuydt, S. Van-belle et al., Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study, Intensive Care Medicine, vol.40, issue.5, pp.889-98, 2013.
DOI : 10.1007/s00134-012-2791-x

Y. Kim, M. Kim, Y. Cho, J. Park, J. Kim et al., Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB???IV lung cancer patients, Medical Oncology, vol.33, issue.3, 2014.
DOI : 10.1007/s12032-014-0847-1

A. Toffart, C. Pizarro, C. Schwebel, L. Sakhri, C. Minet et al., Selection criteria for intensive care unit referral of lung cancer patients: a pilot study, European Respiratory Journal, vol.45, issue.2, pp.491-500, 2015.
DOI : 10.1183/09031936.00118114

I. Moors, F. Pène, É. Lengline, and D. Benoit, Urgent chemotherapy in hematological patients in the ICU, Current Opinion in Critical Care, vol.21, issue.6, pp.559-68, 2015.
DOI : 10.1097/MCC.0000000000000254

M. Darmon, G. Thiery, M. Ciroldi, S. De-miranda, L. Galicier et al., Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy*, Critical Care Medicine, vol.33, issue.11, pp.2488-93, 2005.
DOI : 10.1097/01.CCM.0000181728.13354.0A

D. Benoit, P. Depuydt, K. Vandewoude, F. Offner, T. Boterberg et al., Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit, Intensive Care Medicine, vol.29, issue.1, 2006.
DOI : 10.1007/s00134-005-2836-5

J. Song, G. Suh, M. Chung, H. Kim, O. Kwon et al., Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Support Care Cancer, pp.491-496, 2011.

P. Wohlfarth, T. Staudinger, W. Sperr, A. Bojic, and O. Robak, Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit, Annals of Hematology, vol.62, issue.3, pp.1629-1665, 2014.
DOI : 10.1007/s00277-014-2141-x

E. Azoulay, D. Mokart, F. Pène, J. Lambert, A. Kouatchet et al., Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium???A Groupe de Recherche Respiratoire en R??animation Onco-H??matologique Study, Journal of Clinical Oncology, vol.31, issue.22, pp.312810-312818, 2013.
DOI : 10.1200/JCO.2012.47.2365

M. Van-vliet, M. Van-den-boogaard, J. Donnelly, A. Evers, N. Blijlevens et al., Long-Term Health Related Quality of Life following Intensive Care during Treatment for Haematological Malignancies, PLoS ONE, vol.38, issue.Pt 1, p.87779, 2014.
DOI : 10.1371/journal.pone.0087779.t003

C. Rhee, J. Kang, Y. Kim, J. Kim, H. Yoon et al., Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies, Critical Care, vol.13, issue.6, p.173, 2009.
DOI : 10.1186/cc8149

A. Mirrakhimov, A. Ali, M. Khan, and A. Barbaryan, Tumor lysis syndrome in solid tumors: an up to date review of the literature, Rare Tumors, vol.6, issue.2, 2014.
DOI : 10.4081/rt.2014.5389

G. Jones, A. Will, G. Jackson, N. Webb, S. Rule et al., Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology, British Journal of Haematology, vol.37, issue.5, pp.661-71
DOI : 10.1111/bjh.13403

V. Adam, C. Dooms, and J. Vansteenkiste, Lung cancer at the intensive care unit: The era of targeted therapy. Lung Cancer, pp.218-239, 2015.

K. Kerrigan, A. Shoben, and G. Otterson, Treatment of Lung Cancer Patients With Actionable Mutations in the Intensive Care Unit. Clin Lung Cancer, 2016.

N. Janus, V. Launay-vacher, A. Thyss, H. Boulanger, O. Moranne et al., Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study, Annals of Oncology, vol.24, issue.2, pp.501-508
DOI : 10.1093/annonc/mds344

E. Azoulay, M. Soares, M. Darmon, D. Benoit, S. Pastores et al., Intensive care of the cancer patient: recent achievements and remaining challenges, Annals of Intensive Care, vol.1, issue.1, p.5, 2011.
DOI : 10.1007/s00134-009-1709-8